2025年

発表

1. Koichiro Wada,Kota Saka,Akira Shibahara,Yuki Sakaue,Shota Ohshima,Saori Yoshioka,Yusuke Kobayashi,Hirochika Nakajima,Kohei Ogawa,Chiaki Koike：Antimicrobial Resistance on N. gonorrhoeae and M. genitalium．The 22nd Urological Association of Asia Congress（シンポジウム）．Taipei, Taiwan，2025.8
2. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,中島宏親,小川貢平,小池千明,井上圭太,本田聡,椎名浩昭：Summery of recommendations for urinary tract infections in the JAID/JSC Guide to Clinical Management of Infectious Diseases 2023（JAID/JSC感染症治療ガイド2023を読み解く）．第112回日本泌尿器科学会総会（シンポジウム）．福岡，2025.4
3. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,中島宏親,小川貢平,小池千明,井上圭太,本田聡,椎名浩昭：Summery of recommendations in the Essential Japanese Guidelines for the Prevention of Perioperative Infections in the Urological Field: 2023 Edition（周術期感染症アップデート）．第112回日本泌尿器科学会総会（アップデートシリーズ講演）．福岡，2025.4
4. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,中島宏親,小川貢平,小池千明,井上圭太：泌尿器科領域における周術期感染症予防．第40回日本環境感染学会総会・学術集会（シンポジウム）．横浜，2025.7
5. 和田耕一郎：腎移植について．腎代替療法webセミナー．出雲・Web，2025.2
6. 和田耕一郎：性感染症の現状と課題．第15回日本性感染症学会中国支部総会．岡山，2025.1
7. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,中島宏親,小川貢平,小池千明,井上圭太：性感染症 診断・治療ガイドライン2026の改訂ポイント（非淋菌性尿道炎を含む）．日本性感染症学会 第38回学術大会（シンポジウム）．名古屋，2025.12
8. 和田耕一郎：梅毒と尿道炎．第3回中国地区フレッシャーズキャンプ．出雲，2025.5
9. 和田耕一郎：どうなる？泌尿器感染症 ー漂流中の自分に問うー．第8回札幌尿路感染症研究会．札幌，2025.1
10. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,杉谷智之,中島宏親,小川貢平,小池千明,井上圭太：難治性膀胱炎の病態とマネジメント ―無症候性細菌尿とカテーテル関連尿路感染症を含めて―．第95回日本感染症学会西日本地方会学術集会/第73回日本化学療法学会西日本支部総会 合同学会（ワークショップ）．福岡，2025.11
11. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,杉谷智之,中島宏親,小川貢平,小池千明,井上圭太：尿道炎のマネジメント．第95回日本感染症学会西日本地方会学術集会/第73回日本化学療法学会西日本支部総会 合同学会（シンポジウム）．福岡，2025.11
12. 和田耕一郎,中島宏親,原尚史,坪井一朗,河野慎司,坂上祐樹,田中元,三谷一貴,大島勝太,吉岡彩織,小林祐介,小川貢平,永見太一,小池千明,井上圭太,本田聡,椎名浩昭：島根大学泌尿器科における令和6年手術統計．第342回日本泌尿器科学会岡山地方会．岡山，2025.2
13. 和田耕一郎,坂孝太,芝原彰良,坂上祐樹,大島勝太,原尚史,吉岡彩織,小林祐介,中島宏親,小川貢平,小池千明,井上圭太：泌尿器科領域のロボット手術における周術期感染症予防．第38回日本外科感染症学会総会学術集会（パネルディスカッション）．山形，2025.11

論文

1. Yoshida R, Komatsubara Y, Yoshizako T, Mitani K, Ogawa K, Wada K, Araki A, Kaji Y: Diagnostic challenges in bleeding renal tumors: A ruptured papillary renal cell carcinoma showing regression followed by progression. Radiol Case Rep. 2025 Nov 12;21(2):495-499.
2. Uno M, Tamaki Y, Nonomura K, Yamamori U, Burioka H, Nagano N, Ue A, Sonoyama Y, Yoshida R, Kitajima K, Wada K: Effect of hydrogel-spacer implantation and uneven positioning on rectal dose in intensity-modulated radiotherapy for prostate cancer. J Cancer. 2025 Oct 1;16(14):4187-4195.
3. Ogawa K, Tsuboi I, Tanaka G, Mitani K, Oshima S, Hara T, Kobayashi Y, Nakajima H, Koike C, Wada K: Impact of early unclamping technique on perioperative and postoperative outcomes in robot-assisted laparoscopic partial nephrectomy: a propensity score-matched analysis from a single center. BMC Urol. 2025 Oct 17;25(1):257.
4. Tsuboi I, Kardoust Parizi M, Matsukawa A, Miszczyk M, Fazekas T, Cormio A, Kawada T, Katayama S, Iwata T, Bekku K, Wada K, Karakiewicz PI, Chlosta P, Briganti A, Araki M, Shariat SF: Rectal Swab-based Targeted Prophylactic Antibiotics Reduce Infectious Complications After Transrectal Prostate Biopsy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Open Sci. 2025 Sep 11;80:57-65.
5. Nishimura S, Inoue S, Sekito T, Tsuboi I, Tokunaga M, Yoshinaga K, Maruyama Y, Mitsui Y, Yamanoi T, Kawada T, Kubota R, Sadahira T, Tominaga Y, Iwata T, Katayama S, Bekku K, Edamura K, Wada K, Kobayashi Y, Araki M: Risk Factors for Perioperative Urinary Tract Infection After Living Donor Kidney Transplantation Characterized by High Prevalence of Desensitization Therapy: A Single-Center Analysis. J Clin Med. 2025 Aug 28;14(17):6102.
6. Kubota R, Sada KE, Tokunaga M, Yoshinaga K, Yamanoi T, Kawada T, Tominaga Y, Sadahira T, Katayama S, Iwata T, Nishimura S, Bekku K, Edamura K, Kobayashi T, Nakagawa Y, Ichimaru N, Wada K, Araki M: Risk of malignant neoplasms of tacrolimus in kidney transplant patients: a retrospective cohort study conducted using the Japanese National Database of Health Insurance Claims. BMC Nephrol. 2025 Aug 26;26(1):491.
7. Tsuboi I, Matsukawa A, Parizi MK, Miszczyk M, Fazekas T, Schulz RJ, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Rajwa P, Wada K, Oberneder K, Chlosta P, Karakiewicz PI, Araki M, Shariat SF: Impact of concomitant medications on the oncologic efficacy of systemic therapy in patients with advanced or metastatic urothelial carcinoma: a systematic review and meta-analysis. BMC Urol. 2025 Apr 28;25(1):107.
8. Saito R, Taoka R, Miki J, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Sazuka T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kinoshita H; Japan Urological Oncology Group: Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort. Int J Clin Oncol. 2025 Oct;30(10):2106-2117.
9. Sazuka T, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Sawada A, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ichikawa T; Japan Urological Oncology Group: Impact of lymph-node dissection during radical cystectomy for non-muscle-invasive bladder cancer: Japanese multicenter retrospective study. Int J Clin Oncol. 2025 Jul;30(7):1417-1425.
10. Hatakeyama S, Taoka R, Miki J, Saito R, Fukuokaya W, Matsui Y, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga KI, Yamaguchi N, Taguchi M, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Ohyama C; Japanese Urological Oncology Group: Effects of the Number of Neoadjuvant Cycles and Addition of Adjuvant Chemotherapy on the Prognosis of Muscle-Invasive Bladder Cancer Treated with Radical Cystectomy. Cancer Med. 2025 May;14(9):e70782.
11. Tsuboi I, Matsukawa A, Kardoust Parizi M, Schulz RJ, Mancon S, Fazekas T, Miszczyk M, Cadenar A, Laukhtina E, Rajwa P, Kawada T, Katayama S, Iwata T, Bekku K, Yanagisawa T, Miki J, Kimura T, Wada K, Karakiewicz PI, Chlosta P, Teoh J, Araki M, Shariat SF: Nonintravesical Interventions for Preventing Intravesical Recurrence in Patients with Nonmuscle-Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. Clin Genitourin Cancer. 2025 Apr;23(2):102306.
12. Tsuboi I, Schulz RJ, Laukhtina E, Wada K, Karakiewicz PI, Araki M, Shariat SF: Incidence, Management, and Prevention of Gynecomastia and Breast Pain in Patients with Prostate Cancer Undergoing Antiandrogen Therapy: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Eur Urol Open Sci. 2025 Jan 27;73:31-42.
13. Hara S, Fukuokaya W, Miki J, Taoka R, Saito R, Matsui Y, Hatakeyama S, Kawahara T, Matsuda A, Kawai T, Kato M, Sazuka T, Sano T, Urabe F, Kashima S, Naito H, Murakami Y, Miyake M, Daizumoto K, Matsushita Y, Hayashi T, Inokuchi J, Sugino Y, Shiga K, Yamaguchi N, Yamamoto S, Yasue K, Abe T, Nakanishi S, Hashine K, Fujii M, Nishihara K, Matsumoto H, Tatarano S, Wada K, Sekito S, Maruyama R, Nishiyama N, Nishiyama H, Kitamura H, Kimura T; Japan Urological Oncology Group: Stage III substaging and outcomes in patients with bladder cancer undergoing radical cystectomy. Int J Urol. 2025 May;32(5):544-552.
14. Tohi Y, Kobayashi K, Daizumoto K, Sekino Y, Fukuhara H, Niigawa H, Katayama S, Shimizu R, Takamoto A, Nishimura K, Nagami T, Hayashida Y, Hirama H, Shiraishi K, Tomida R, Kobatake K, Inoue K, Miyaji Y, Bekku K, Morizane S, Miura N, Wada K, Sugimoto M; Chu-shikoku Japan Urological Consortium: Real-world clinical usage and efficacy of apalutamide in men with nonmetastatic castration-resistant prostate cancer: a multi-institutional study in the CsJUC. Jpn J Clin Oncol. 2025 Jun 5;55(6):643-649.
15. Sadahira T, Sekito T, Maruyama Y, Ichikawa T, Kurihara Y, Shiraishi H, Sakuma T, Tokunaga M, Mitsui Y, Kusumi N, Tominaga Y, Katayama S, Iwata T, Nishimura S, Edamura K, Kobayashi T, Watanabe M, Hiyama Y, Yamada H, Kurata H, Kondo T, Mitsui M, Takenaka T, Kiyota H, Araki M, Miyazaki J, Takahashi S, Yamamoto S, Wada K: Significance of Targeted Antimicrobial Prophylaxis Using Rectal-culture Selective Screening Media Prior to Transrectal Prostate Biopsy: A Multicenter, Randomized Controlled Trial. Urology. 2025 Feb;196:32-39.
16. Tsuboi I, Rajwa P, Campi R, Miszczyk M, Fazekas T, Matsukawa A, Kardoust Parizi M, Schulz RJ, Mancon S, Cadenar A, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Wada K, Karakiewicz PI, Remzi M, Araki M, Shariat SF: Oncological Outcomes of Active Surveillance versus Surgery or Ablation for Patients with Small Renal Masses: A Systematic Review and Quantitative Analysis. Eur Urol Oncol. 2025 Apr;8(2):544-553.
17. Tsuboi I, Kardoust Parizi M, Matsukawa A, Mancon S, Miszczyk M, Schulz RJ, Fazekas T, Cadenar A, Laukhtina E, Kawada T, Katayama S, Iwata T, Bekku K, Wada K, Remzi M, Karakiewicz PI, Araki M, Shariat SF: The efficacy of adjuvant mitotane therapy and radiotherapy following adrenalectomy in patients with adrenocortical carcinoma: A systematic review and meta-analysis. Urol Oncol. 2025 May;43(5):297-306.
18. Parizi MK, Singla N, Daneshmand S, Heidenreich A, Bagrodia A, Margulis V, Matsukawa A, Tsuboi I, Shariat SF: Late relapse of testicular germ cell tumor: An individual patient data meta-analysis of disease characteristics, treatments, and oncological outcomes. Cent European J Urol. 2025;78(3):289-304.
19. Matsukawa A, Yanagisawa T, Rajwa P, Fazekas T, Miszczyk M, Tsuboi I, Parizi MK, Laukhtina E, Klemm J, Chiujdea S, Mancon S, Mori K, Kimura S, Karakiewicz PI, Miki J, Kimura T, Shariat SF: Central Nervous System Toxicity in Prostate Cancer Patients Treated with Androgen Receptor Signaling Inhibitors: A Systematic Review, Meta-analysis, and Network Meta-analysis. Clin Genitourin Cancer. 2025 Feb;23(1):102251.
20. Matsumoto M, Hamasuna R, Wada K, Sadahira T, Shigemura K, Maeda K, Hiyama Y, Togo Y, Nagasawa S, Yamanaka K, Shigehara K, Kobayashi K, Tsuchiya H, Miyazaki J, Nakagawa T, Ishikawa K, Takahashi S, Fujimoto N, Yamamoto S: Fluoroquinolone resistance and clinical characteristics of acute bacterial prostatitis in Japan: A multicenter study by the Japanese research group for urinary tract infection. J Infect Chemother. 2025 Jan;31(1):102497.
21. Miszczyk M, Fazekas T, Rajwa P, Matsukawa A, Tsuboi I, Leapman MS, Kramer G, Hussain M, Merseburger A, Briganti A, D’Amico AV, Gillessen S, Saad F, Shariat SF: Prostate-specific Antigen Response as a Prognostic Factor for Overall Survival in Patients with Prostate Cancer Treated with Androgen Receptor Pathway Inhibitors: A Systematic Review and Meta-analysis. Eur Urol Focus. 2025 Sep;11(5):755-766.
22. Miszczyk M, Stando R, Francolini G, Zamboglou C, Cadenar A, Suleja A, Fazekas T, Matsukawa A, Tsuboi I, Przydacz M, Leapman MS, Rajwa P, Supiot S, Shariat SF: Perirectal spacers in radiotherapy for prostate cancer – a systematic review and meta-analysis. Contemp Oncol (Pozn). 2025;29(1):36-44.
23. Matsukawa A, Cormio A, Miszczyk M, Parizi MK, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Litterio G, Laukhtina E, Rajwa P, Seisen T, Mori K, Sanguedolce F, Galosi AB, Miki J, Kimura T, Shariat SF, Yanagisawa T: Impact of Immune Checkpoint Inhibitors as Neoadjuvant Therapy for Muscle-invasive Bladder Cancer: A Systematic Review, Meta-analysis, and Network Meta-analysis. Eur Urol Oncol. 2025 Dec;8(6):1673-1684.
24. Miszczyk M, Bilski M, Kói T, Konat-Bąska K, Suleja A, Fazekas T, Matsukawa A, Tsuboi I, Schulz R, Rajwa P, Laukhtina E, Hassler MR, Marvaso G, Sargos P, Ost P, Ploussard G, Jereczek-Fossa B, Roupret M, Chłosta P, Karakiewicz PI, Babjuk M, Teoh JY, Moschini M, Gontero P, Shariat SF: Metastasis-directed Therapy in the Management of Urothelial Carcinoma: A Systematic Review and Meta-analysis. Eur Urol Focus. 2025 Jul;11(4):638-647.
25. Kardoust Parizi M, Singla N, Daneshmand S, Heidenreich A, Bagrodia A, Margulis V, Matsukawa A, Tsuboi I, Shariat SF: Diagnostic efficacy of serum microRNAs in predicting pathology of retroperitoneal lymph node dissection in patients with testicular germ cell tumors: a systematic review and meta-analysis. World J Urol. 2025 Mar 27;43(1):192.
26. Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review.Fazekas T, Pallauf M, Kufel J, Miszczyk M, Tsuboi I, Matsukawa A, Laukhtina E, Kardoust Parizi M, Mancon S, Cadenar A, Schulz R, Yanagisawa T, Baboudjian M, Szarvas T, Gandaglia G, Tilki D, Nyirády P, Rajwa P, Leapman MS, Shariat SF.Eur Urol Oncol. 2025 Oct;8(5):1352-1364.
27. Kardoust Parizi M, Singla N, Rouprêt M, Margulis V, Matsukawa A, Tsuboi I, Schulz R, Karakiewicz PI, Teoh JY, Soria F, Shariat SF: The role of surgical resection of the primary tumor in metastatic upper tract urothelial carcinoma: a systematic review and meta-analysis. Curr Opin Urol. 2025 May 1;35(3):284-291.
28. Matsukawa A, Litterio G, Cormio A, Miszczyk M, Kardoust Parizi M, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Laukhtina E, Rajwa P, Mori K, Chlosta P, Marchioni M, Schips L, Miki J, Kimura T, Shariat SF, Yanagisawa T: An Updated Systematic Review and Network Meta-Analysis of First-Line Triplet vs. Doublet Therapies for Metastatic Hormone-Sensitive Prostate Cancer. Cancers (Basel). 2025 Jan 9;17(2):205.
29. Matsukawa A, Yanagisawa T, Miszczyk M, Parizi MK, Fazekas T, Tsuboi I, Mancon S, Schulz RJ, Litterio G, Laukhtina E, Rajwa P, Urabe F, Mori K, Miki J, Karakiewicz PI, Chlosta P, Kimura T, Cussenot O, Shariat SF: Incidence and Outcomes of Secondary Bladder Cancer Following Radiation Therapy for Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol Focus. 2025 May;11(3):471-481.
30. Kardoust Parizi M, Singla N, Matsukawa A, Tsuboi I, Mancon S, Miszczyk M, Chlosta P, Shariat SF: Efficacy of human papillomavirus vaccines in the prevention of male genital diseases: a systematic review. BJU Int. 2025 Jun;135(6):902-907.
31. Matsukawa A, Yanagisawa T, Miszczyk M, Kardoust Parizi M, Fazekas T, Tsuboi I, Mancon S, Klemm J, Schulz R, Cadenar A, Laukhtina E, Rajwa P, Mori K, Miki J, Kimura T, Shariat SF: Trimodality Therapy Versus Radical Cystectomy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Matched Cohort Studies. Eur Urol Focus. 2025 Mar;11(2):374-385.
32. Tanegashima T, Shiota M, Terada N, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S, Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Kitamura H, Kamoto T, Eto M; Japanese Urological Oncology Group: Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer. Int J Clin Oncol. 2025 Mar;30(3):551-558.
33. Matsukawa A, Yanagisawa T, Fazekas T, Miszczyk M, Tsuboi I, Kardoust Parizi M, Laukhtina E, Klemm J, Mancon S, Mori K, Kimura S, Miki J, Gomez Rivas J, Soeterik TFW, Zilli T, Tilki D, Joniau S, Kimura T, Shariat SF, Rajwa P: Salvage therapies for biochemical recurrence after definitive local treatment: a systematic review, meta-analysis, and network meta-analysis. Prostate Cancer Prostatic Dis. 2025 Sep;28(3):610-622.